STAAR Surgical Co. (STAA)
18.95
-0.24
(-1.25%)
USD |
NASDAQ |
Mar 26, 13:33
STAAR Surgical Cash from Investing (Quarterly) : -19.42M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| The Cooper Cos., Inc. | -102.90M |
| OrthoPediatrics Corp. | -7.259M |
| NexGel, Inc. | -0.008M |
| Innovative Eyewear, Inc. | -0.0148M |
| Abbott Laboratories | -913.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.914M |
| Cash from Financing (Quarterly) | -0.05M |
| Free Cash Flow | -40.05M |
| Free Cash Flow Per Share (Quarterly) | -0.1124 |
| Free Cash Flow to Equity (Quarterly) | -4.827M |
| Free Cash Flow to Firm (Quarterly) | -5.591M |
| Free Cash Flow Yield | -4.24% |